Rare diseases: How do we weigh the costs and benefits of new treatments?

What happens when we study rare medical disorders? Rare conditions, by their very nature, are not common, leading to people with these afflictions often feeling overlooked. At the same time, researchers are gaining insight and developing new treatments that are raising hopes for those afflicted with some rare disorders. We’ll take a look at the interesting, and often thorny, issues that surround treatment and research of rare disorders with our panel of experts in the field.

Panelists:

Scott McIvor, Genetics, Cell Biology and Development, College of Biological Sciences and University of Minnesota Medical School

Stephen Parente, Finance, Carlson School of Management

Reena Kartha, Experimental and Clinical Pharmacology, and Translational Pharmacology, College of Ph*rm*cy

Doors open at 5:45 p.m. Program starts at 6:15 p.m.

Organized by the University of Minnesota's College of Biological Sciences In collaboration with the Bell Museum.

About Petri Dish

The Petri Dish explores how biology affects our lives and what it means for our future. No PowerPoints. Just lively, curiosity-driven conversations on timely topics with University of Minnesota experts.

Host or Publisher University of Minnesota College of Biological Sciences